EP 1324759 A4 20040512 - NF-G(K)B INHIBITORS
Title (en)
NF-G(K)B INHIBITORS
Title (de)
NF--G(K)B INHIBITOREN
Title (fr)
INHIBITEURS DU NF-G(K)B
Publication
Application
Priority
- US 0131866 W 20011012
- US 23975900 P 20001012
Abstract (en)
[origin: WO0230353A2] The present invention provides novel compounds and methods for treating diseases with aminothiophene inhibitors of IKK-ss phosphorylation of I kappa B.
IPC 1-7
IPC 8 full level
C07D 333/38 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61P 1/04 (2006.01); A61P 3/10 (2006.01); A61P 7/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 409/04 (2006.01)
CPC (source: EP)
A61K 31/38 (2013.01); A61P 1/04 (2017.12); A61P 3/10 (2017.12); A61P 7/00 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/10 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [PX] WO 0158890 A1 20010816 - ASTRAZENECA AB [SE], et al
- [E] WO 0198290 A2 20011227 - PHARMACIA & UPJOHN SPA [IT], et al
- [A] EP 0853083 A1 19980715 - PFIZER [US]
- See references of WO 0230353A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0230353 A2 20020418; WO 0230353 A3 20020627; AU 1166302 A 20020422; EP 1324759 A2 20030709; EP 1324759 A4 20040512; JP 2004523476 A 20040805
DOCDB simple family (application)
US 0131866 W 20011012; AU 1166302 A 20011012; EP 01979731 A 20011012; JP 2002533800 A 20011012